RegenLab USA

RegenLab is recognized as a global leader in medical biotechnologies, specializing in cellular therapies, manufactured in the USA. RegenLab is at the forefront of innovation, with an expertly designed medical device for the preparation of platelet rich plasma from the patients own blood. Regen A-PRP is FDA cleared and developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over one million treatments worldwide using RegenLab products. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine

Biotechnology,regenerative medicine,platelet rich plasma,cellular therapies,medical devices,orthobiologics,and aesthetics

Regenlab usa operates in the Medical device industry.

Regenlab usa's revenue is 11m - 100m

Regenlab usa has 11 - 50 employees.